| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diarrhea | D003967 | 32 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Abscess | D000038 | 13 associated lipids |
| Fractures, Spontaneous | D005598 | 4 associated lipids |
| Osteomyelitis | D010019 | 10 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Intraoperative Complications | D007431 | 5 associated lipids |
| Drug Hypersensitivity | D004342 | 20 associated lipids |
| Hyperbilirubinemia | D006932 | 11 associated lipids |
| Anaphylaxis | D000707 | 35 associated lipids |
Rifamycin SV
Rifamycin SV is a lipid of Polyketides (PK) class. Rifamycin sv is associated with abnormalities such as Cholestasis, Infection, Dysentery, Soft Tissue Infections and Osteomyelitis. The involved functions are known as Uptake, Excretory function, Drug Kinetics, inhibitors and anaphylaxis. Rifamycin sv often locates in Hepatic, Blood, soluble, Entire gastrointestinal tract and Membrane. The associated genes with Rifamycin SV are SLCO1C1 gene, SLCO1B1 gene, ABCB11 gene and SLC10A1 gene.
Cross Reference
Introduction
To understand associated biological information of Rifamycin SV, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Rifamycin SV?
Rifamycin SV is suspected in Tuberculosis, Cholestasis, Infection, Dysentery, Soft Tissue Infections, Osteomyelitis and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Rifamycin SV
PubChem Associated disorders and diseases
What pathways are associated with Rifamycin SV
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Rifamycin SV?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Rifamycin SV?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
What genes are associated with Rifamycin SV?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Rifamycin SV?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Rifamycin SV
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Dechert-Schmitt AM et al. | Polyketide construction via hydrohydroxyalkylation and related alcohol C-H functionalizations: reinventing the chemistry of carbonyl addition. | 2014 | Nat Prod Rep | pmid:24514754 |
| Woods LA et al. | Ligand binding to distinct states diverts aggregation of an amyloid-forming protein. | 2011 | Nat. Chem. Biol. | pmid:21873994 |
| Okolicsanyi L et al. | Influence of rifamycin SV on bile acid metabolism in rats. | 1980 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:7422017 |
| Wang EJ et al. | Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites. | 2003 | Pharm. Res. | pmid:12739759 |
| Swift B et al. | Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes. | 2010 | Pharm. Res. | pmid:20652625 |
| Evans SE et al. | The ansamycin antibiotic, rifamycin SV, inhibits BCL6 transcriptional repression and forms a complex with the BCL6-BTB/POZ domain. | 2014 | PLoS ONE | pmid:24595451 |
| Velichka D et al. | Experimental and clinical studies on Rifacinna--the new effective antituberculous drug (review). | 2010 | Recent Pat Antiinfect Drug Discov | pmid:19929844 |
| Crance JM et al. | Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds. | 1997 Sep-Oct | Res. Virol. | pmid:9403935 |
| Păunescu E et al. | [Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis]. | 1982 Apr-Jun | Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol | pmid:6294806 |
| Marchesoni A et al. | Rifamycin SV versus triamcinolone in local treatment of rheumatoid synovitis. | 1993 | Scand. J. Rheumatol. | pmid:8356413 |